We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$330M
2
CTRA
Coterra Energy
CTRA
+$214M
3
BSX icon
Boston Scientific
BSX
+$204M
4
RBA icon
RB Global
RBA
+$183M
5
CVX icon
Chevron
CVX
+$131M

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCL icon
101
Royal Caribbean
RCL
$78.7B
$123M 0.19%
448,400
+237,100
+112% +$70.6M
QCOM icon
102
Qualcomm
QCOM
$176B
$123M 0.19%
955,821
+17,300
+2% +$2.53M
LBRDK icon
103
Liberty Broadband Class C
LBRDK
$4.15B
$122M 0.19%
2,433,667
+509,722
+26% +$25.7M
CVE icon
104
Cenovus Energy
CVE
$54.6B
$121M 0.19%
4,578,262
-790,000
-15% -$16.8M
AMGN icon
105
Amgen
AMGN
$203B
$121M 0.19%
342,500
+68,208
+25% +$24.3M
TAK icon
106
Takeda Pharmaceutical
TAK
$55.1B
$119M 0.18%
+6,424,984
New +$113M
SLAB icon
107
Silicon Laboratories
SLAB
$7.15B
$118M 0.18%
566,337
-50,138
-8% -$9.19M
SPGI icon
108
S&P Global
SPGI
$126B
$117M 0.18%
274,120
-500
-0.2% -$232K
ETN icon
109
Eaton
ETN
$157B
$115M 0.18%
322,898
+7,828
+2% +$2.79M
DASH icon
110
DoorDash
DASH
$75.3B
$115M 0.18%
764,900
+427,400
+127% +$79M
CVS icon
111
CVS Health
CVS
$137B
$115M 0.18%
1,596,630
-124,636
-7% -$9.6M
SO icon
112
Southern Company
SO
$110B
$115M 0.18%
+1,186,900
New +$110M
ANET icon
113
Arista Networks
ANET
$219B
$114M 0.18%
925,100
+7,900
+0.9% +$1.06M
ETR icon
114
Entergy
ETR
$54.1B
$113M 0.17%
1,008,204
+405,000
+67% +$40.7M
BKNG icon
115
Booking.com
BKNG
$138B
$113M 0.17%
672,500
-36,250
-5% -$6.67M
VRTX icon
116
Vertex Pharmaceuticals
VRTX
$121B
$113M 0.17%
251,990
-20,484
-8% -$9.55M
SDRL icon
117
Seadrill
SDRL
$2.81B
$112M 0.17%
2,463,436
-1,021,504
-29% -$41.7M
TERN
118
DELISTED
Terns Pharmaceuticals
TERN
$112M 0.17%
2,124,817
-3,425,183
-62% -$141M
LMT icon
119
Lockheed Martin
LMT
$134B
$111M 0.17%
184,393
+31,400
+21% +$19.3M
VTR icon
120
Ventas
VTR
$48.9B
$110M 0.17%
1,345,500
+19,474
+1% +$1.59M
SR icon
121
Spire
SR
$4.92B
$109M 0.17%
1,201,440
+78,220
+7% +$6.86M
BLK icon
122
Blackrock
BLK
$164B
$107M 0.16%
110,964
-500
-0.4% -$526K
HUBB icon
123
Hubbell
HUBB
$25.7B
$106M 0.16%
216,567
-272,330
-56% -$134M
MDLZ icon
124
Mondelez International
MDLZ
$77.7B
$106M 0.16%
1,833,297
+479,100
+35% +$27.7M
SHW icon
125
Sherwin-Williams
SHW
$78.3B
$105M 0.16%
328,506
+218,200
+198% +$75.1M
3 4
5
6 7

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.